Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 1/20 | 0.64 |
| ▸ | NAAA | Q02083 | 3/20 | 0.56 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.56 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.56 |
| ▸ | HRH4 | Q9H3N8 | 1/20 | 0.50 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.50 |
| ▸ | IDO1 | P14902 | 1/20 | 0.46 |
| ▸ | EPHX2 | P34913 | 2/20 | 0.46 |
| ▸ | AGXT | P21549 | 1/20 | 0.44 |
| ▸ | LTA4H | P09960 | 1/20 | 0.44 |
| ▸ | GBA1 | P04062 | 2/20 | 0.44 |
| ▸ | UGCG | Q16739 | 2/20 | 0.44 |
| ▸ | GBA2 | Q9HCG7 | 2/20 | 0.44 |
| ▸ | ADRB2 | P07550 | 1/20 | 0.44 |
| ▸ | ADRB1 | P08588 | 1/20 | 0.44 |
| ▸ | ADRB3 | P13945 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16595002 | 1.00 | TSHR (0.64) | TSHRNAAAL3MBTL1TDP1HRH4 | |
| SCHEMBL20535824 | 0.98 | TSHR (0.61) | TSHRNAAAL3MBTL1TDP1HRH4 | |
| SCHEMBL23405397 | 0.98 | TSHR (0.61) | TSHRNAAAL3MBTL1TDP1HRH4 | |
| SCHEMBL16594712 | 0.98 | TSHR (0.61) | TSHRNAAAL3MBTL1TDP1HRH4 | |
| SCHEMBL9011595 | 0.98 | TSHR (0.67) | TSHRNAAAL3MBTL1TDP1HRH4 | |
| SCHEMBL25195898 | 0.95 | TSHR (0.64) | TSHRNAAAL3MBTL1TDP1HRH4 | |
| SCHEMBL2640223 | 0.95 | TSHR (0.70) | TSHRNAAAL3MBTL1TDP1HRH4 | |
| SCHEMBL9011734 | 0.93 | TSHR (0.67) | TSHRNAAAL3MBTL1TDP1HRH4 | |
| SCHEMBL9011624 | 0.93 | TSHR (0.67) | TSHRNAAAL3MBTL1TDP1HRH4 | |
| SCHEMBL9011715 | 0.93 | TSHR (0.67) | TSHRNAAAL3MBTL1TDP1HRH4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3052465-B1 | POLYFUNCTIONALIZED POLYETHYLENE AND POLYPROPYLENE GLYCOL USEFUL AS TRACERS | RESMAN AS (NO) | 2020-07-29 | — | — | EP | claimed |
| US-10364217-B2 | Chemical compounds | RESMAN AS (NO) | 2019-07-30 | — | — | US | claimed |
| EP-3052465-B1 | POLYFUNCTIONALIZED POLYETHYLENE AND POLYPROPYLENE GLYCOL USEFUL AS TRACERS | RESMAN AS (NO) | 2020-07-29 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10364217-B2 | Chemical compounds | PTGES, PTGIS, PTGFR | TSHR 3608/4885NAAA 2263/4885L3MBTL1 4327/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.